Annals of Internal Medicine
REVIEWS
Mosquitoes and Mosquito Repellents: A Clinician's Guide
Annals
of Internal Medicine, 1 June 1998. 128:931-940.
Mark S. Fradin, MD
This paper is intended to provide the clinician with the detailed and
scientific information needed to advise patients who seek safe and
effective ways of preventing mosquito bites. For this review, clinical and
analytical data were selected from peer-reviewed research studies and
review articles, case reports, entomology texts and journals, and
government and industry publications. Relevant information was identified
through a search of the MEDLINE database, the World Wide Web, the
Mosquito-L electronic mailing list, and the Extension Toxicology Network
database; selected U.S. Army, U.S. Environmental Protection Agency, and
U.S. Department of Agriculture publications were also reviewed.
N,N-diethyl-3-methylbenzamide (DEET) is the most effective, and best
studied, insect repellent currently on the market. This substance has a
remarkable safety profile after 40 years of worldwide use, but toxic
reactions can occur (usually when the product is misused). When DEET-based
repellents are applied in combination with permethrin-treated clothing,
protection against bites of nearly 100% can be achieved. Plant-based
repellents are generally less effective than DEET-based products.
Ultrasonic devices, outdoor bug "zappers," and bat houses are not
effective against mosquitoes. Highly sensitive persons may want to take
oral antihistamines to minimize cutaneous reactions to mosquito bites.
Ann Intern Med. 1998;128:931-940. Annals of Internal
Medicine is published twice monthly and copyrighted © 1998 by the
American College of Physicians.
The quest to make humans less attractive to mosquitoes has fueled
decades of scientific research on mosquito behavior and control. In the
United States, mosquito bites are mostly a nuisance. Worldwide, however,
mosquitoes transmit disease to more than 700 000 000 people annually and
will be responsible for the deaths of 1 of every 17 people currently alive (1). Malaria results from infection with a protozoan carried by
mosquitoes and, according to reports from the World Health Organization,
causes as many as 3 000 000 deaths annually (2). Mosquitoes
transmit the arboviruses responsible for yellow fever, dengue hemorrhagic
fever, epidemic polyarthritis, and several forms of encephalitis (some of
which are found in the United States). Bancroftian filariasis is caused by
a nematode transmitted by mosquito bite.
Historically, the strategies for reducing the incidence of
mosquito-borne disease have been two-pronged, centering around habitat
control (through chemical and biological means) and the use of personal
protection in the form of insect repellents. This paper reviews the
scientific data on chemical (synthetic) and natural (plant-derived) insect
repellents currently available, debunks some of the popular myths about
alternative repellents, reviews effective techniques for reducing mosquito
populations in the local environment, and provides the clinician with the
practical information needed to advise patients on how to safely and
effectively reduce their likelihood of being bitten by mosquitoes.
Methods
By doing a MEDLINE search with the keywords DEET, insect repellents,
mosquito, citronella, and permethrin, pertinent articles
published in English-language journals between 1966 and 1997 were
identified and reviewed. The World Wide Web and the Extension Toxicity
Network database were also searched for toxicology data and other
pertinent information. Selection from the bibliographies of relevant
articles augmented the database search. Major distributors of natural
insect repellents were contacted and asked to provide scientific data, if
available, supporting the efficacy of their products.
The Mosquito Life Cycle
Mosquitoes are found all over the world, except in Antarctica. These
two-winged insects belong to the order Diptera. Members of the genera Anopheles, Culex, and Aedes are most commonly
responsible for bites in humans. There are approximately 170 species of
mosquitoes in North America alone.
To develop, mosquitoes require an environment of standing water. As a
group, they have adapted to complete their life cycle in diverse aquatic
habitats, including fresh water; salt water marshes; brackish water; or
water found in containers, old tires, or tree holes. The life cycle of the
mosquito has four stages. The female mosquito lays her eggs, up to several
hundred at a time, on the surface of the water or in an area subject to
flooding. Unhatched eggs of some species can withstand weeks to months of
desiccation, remaining viable until the right conditions for hatching
occur. The eggs of most species hatch in 2 to 3 days, and the larvae feed
on organic matter in the water for about a week until they change into
pupae. The pupae live at the surface of the water for 2 to 3 days before
metamorphosing into adult mosquitoes.
Only female mosquitoes bite. Male mosquitoes feed primarily on flower
nectar, whereas female mosquitoes require a blood meal to produce eggs.
They usually feed every 3 to 4 days; in a single feeding, a female
mosquito typically consumes more than its own weight in blood (3).
Certain species of mosquitoes prefer to feed at twilight or nighttime;
others bite mostly during the day.
Some mosquito species are zoophilic (preferring to feed on animals) and
others are anthropophilic (showing a preference for human blood). In some
mosquito species, seasonal switching of hosts provides a mechanism for
transmitting diseases from animal to human. (It is worth noting, however,
that mosquitoes cannot transmit HIV because the virus neither survives nor
replicates in mosquitoes and the blood from the last bitten person is not
flushed into the next person during subsequent feeds. In addition, the
circulating viral load of most HIV-infected persons is so low that the
theoretical risk that a mosquito bite would transmit HIV is estimated to
be less than 1 in 10 000 000 [4, 5].)
Stimuli That Attract Mosquitoes
The factors involved in attracting mosquitoes to a host are complex and
are not fully understood (6-11). Mosquitoes use visual, thermal,
and olfactory stimuli to locate a host. Of these, olfactory cues are
probably most important. For mosquitoes that feed during the daytime,
movement of the host and the wearing of dark-colored clothing may initiate
orientation toward a person (3, 12). Visual stimuli seem to be
important for in-flight orientation, particularly over long ranges,
whereas olfactory stimuli become more important as a mosquito nears its
host.
It has been estimated that 300 to 400 compounds are released from the
body as by-products of metabolism and that more than 100 volatile
compounds can be detected in human breath (9). Of these odors, only
a fraction have been isolated and fully characterized. Carbon dioxide and
lactic acid are the two best-studied mosquito attractants. Carbon dioxide,
released mainly from breath but also from skin, serves as a long-range
airborne attractant and can be detected by mosquitoes at distances of up
to 36 meters (3, 13-15). Lactic acid, in combination with carbon dioxide,
is also an attractant. Mosquitoes have chemoreceptors on their antennae
that are stimulated by lactic acid. These same receptors may be inhibited
by N,N-diethyl-3-methylbenzamide (DEET)-based insect repellents (16).
At close range, skin temperature and moisture serve as attractants (3, 9, 17). Different species of mosquitoes may show strong biting
preferences for different parts of the human body (such as the head or
feet), which may be related to local skin temperature and eccrine sweat
gland output (18, 19). Anhidrotic persons show markedly decreased
attractiveness to mosquitoes (6). Other volatile compounds, derived
from sebum, eccrine and apocrine sweat, or the cutaneous microflora
bacterial action on these secretions, may also act as chemoattractants (6, 20, 21). Whole-host odors are more attractive than carbon
dioxide and lactic acid alone (22). Floral fragrances from
perfumes, soaps, lotions, and hair-care products may also attract
mosquitoes (23).
The attractiveness of different persons to the same or different
species of mosquitoes varies substantially (17, 24). In general,
adults are more likely to be bitten than children (17, 25),
although adults may become less attractive to mosquitoes as they age (6). Men are bitten more readily than women (3, 26). Larger
persons tend to attract more mosquitoes, perhaps because of their greater
relative heat or carbon dioxide output (27).
Insect Repellents
Despite the obvious desirability of finding an effective oral mosquito
repellent, no such agent has been identified (28, 29). Thus, the search
for the perfect topical insect repellent continues. This ideal agent would
repel multiple species of biting arthropods, remain effective for at least
8 hours, cause no irritation to the skin or mucous membranes, cause no
systemic toxicity, be resistant to abrasion and rub-off, and be greaseless
and odorless. No available insect repellent meets all of these
criteria.
Efforts to find such a compound have been hampered by the numerous
variables that affect the inherent repellency of any chemical. Repellents
do not all share a single mode of action, and surprisingly little is known
about how repellents act on their target insects (30, 31).
Moreover, different species of mosquitoes may react differently to the
same repellent (32).
To be effective, a repellent must show an optimal degree of volatility,
making it possible for an effective repellent vapor concentration to be
maintained at the skin surface without evaporating so quickly that it
loses its effectiveness. Many factors play a role in how effective any
repellent is, including the frequency and uniformity of application, the
number and species of the organisms attempting to bite, the user's
inherent attractiveness to blood-sucking arthropods, and the overall
activity level of the potential host (33). Abrasion from clothing,
evaporation and absorption from the skin surface, wash-off from sweat or
rain, higher temperatures, or a windy environment all decrease repellent
effectiveness (17, 34-37). Each 10 °C increase in temperature can lead to
as much as a 50% reduction in protection time (37). The repellents
currently available must be applied to all exposed areas of skin;
unprotected skin a few centimeters away from a treated area can be
attacked by hungry mosquitoes (33, 35).
Chemical Insect Repellents
N,N-Diethyl-3-Methylbenzamide (DEET)
Previously called N,N-diethyl-m-toluamide,
N,N-diethyl-3-methylbenzamide (DEET) remains the gold standard of
currently available insect repellents. This substance was discovered and
developed by scientists at the U.S. Department of Agriculture and was
patented by the U.S. Army in 1946. It was subsequently registered for use
by the general public in 1957. It is a broad-spectrum repellent that is
effective against mosquitoes, biting flies, chiggers, fleas, and ticks.
Twenty years of empirical testing of more than 20 000 other compounds has
not resulted in another marketed chemical product with the duration of
protection and broad-spectrum effectiveness of DEET (30, 33,
38-41). The U.S. Environmental Protection Agency (EPA) estimates that
more than 38% of the U.S. population uses a DEET-based insect repellent
every year and that worldwide use exceeds 200 000 000 people annually (42).
Formulation of Available Products with DEET
In the United States, DEET is available in 5% to 100% concentrations in
multiple formulations, including solutions, lotions, creams, gels, aerosol
and pump sprays, and impregnated towelettes (Table 1).
Until 1989, the standard-issue insect repellent of the U.S. military
consisted of 75% DEET in an alcohol base. Complaints about the aesthetic
feel of this product and concerns about potential toxicity under long-term
daily use led to U.S. Army-sponsored studies to produce new formulations.
The 3M Company (St. Paul, Minnesota) developed a slow-release,
polymer-based product containing 35% DEET; this has become the repellent
provided to all U.S. military personnel. This product is available to the
general public exclusively through the Amway Corporation (New York, New
York) under the brand name HourGuard (Table 1). If lower-strength
formulations of extended-release DEET are desired, Minnetonka Brands (Eden
Prairie, Minnesota) offers products containing 6.5% and 10% DEET (Table
1).
Efficacy
As a general rule, higher concentrations of DEET provide longer-lasting
protection. Unfortunately, no guidelines are available to help consumers
decide what concentration of DEET is appropriate for their specific needs.
The number of variables that affect a repellent's effectiveness precludes
assigning an "insect repellent factor" to individual products.
Mathematical models of the effectiveness and persistence of mosquito
repellents show that the protection offered by a repellent is proportional
to the logarithm of the dose (concentration of the product). This curve
tends to form a plateau at higher repellent concentrations, providing
relatively less additional protection for each incremental dose of DEET
that exceeds a 50% concentration (43, 44). In one laboratory study,
50% DEET provided about 4 hours of protection against Aedes aegypti
mosquitoes, but increasing the DEET concentration to 100% provided only 1
additional hour of protection (45). In another study, 12.5% DEET
provided over 6 hours of protection against Aedes albopictus;
doubling the DEET concentration to 25% increased the protection time only
to about 8 hours (46).
Extended-release formulations of DEET have made it possible to reduce
the repellent concentration without sacrificing duration of action. When
tested under laboratory and several different environmental and climatic
field conditions, the 35% DEET polymer formulation by the 3M Corporation
was as effective as 75% DEET in repelling mosquitoes (19, 47-50).
The polymer formulation provided up to 12 hours of more than 95%
protection, depending on the environmental conditions and species of
mosquito tested (46, 48, 49, 51). One study showed that Minnetonka
Brands' 6.5% liposphere microdispersion of DEET was effective for up to
2.5 hours and that their 10% product was effective for about 1 hour longer (52).
How To Choose and Apply DEET Repellents
For casual use, a high concentration of DEET is not needed. Products
with 10% to 35% DEET will provide adequate protection under most
conditions. The American Academy of Pediatrics recommends that repellents
used on children contain no more than 10% DEET (53, 54). Products with a
DEET concentration of more than 50% are probably best reserved for
circumstances in which insect biting pressures are intense and in which
other factors, such as high temperature and humidity, may promote rapid
loss of repellent from the skin surface. The EPA issued guidelines to
consumers about proper application of insect repellents (Table 2) (55).
Repellents may be applied directly to the skin or to clothing, window
screens, mesh insect nets, tents, or sleeping bags. Persons who are
particularly concerned about potential toxicity from DEET may limit
application of the repellent to their clothes. If DEET-treated garments
are stored in a plastic bag between wearings, the repellent effect can
last for many weeks (24).
Repellents containing DEET must be carefully applied because they can
damage plastics (such as watch crystals and eyeglasses frames), rayon,
spandex, other synthetic fabrics, leather, and painted or varnished
surfaces. DEET does not damage natural fibers, such as cotton or wool, and
has no effect on nylon. The lay literature contains many accounts of the
unpleasant odor or greasy feel of DEET, but careful testing has shown a
full spectrum of aesthetic responses to these products (56).
Consumers who apply both a DEET-based insect repellent and a sunscreen
should be aware that the repellent may reduce the sunscreen's
effectiveness. A limited study in 14 volunteers using the 3M polymer-based
33% DEET repellent and a sunscreen with sun protection factor 15 revealed
a mean decrease in sun protection factor of 33.5% when the two agents were
applied sequentially (57). Combination products in which the insect
repellent and sunscreen have been formulated together, however, would be
expected to provide the sun protection factor stated on the label.
Pharmacology
Numerous studies have evaluated the percutaneous absorption,
metabolism, and rate of excretion of DEET (58-61). Initial data
suggested that 9% to 56% of the applied dose was absorbed through the skin (59). A carefully conducted study from 1995 that used human
volunteers showed that the average dermal absorption of 100% DEET was
5.6%; for 15% DEET in ethanol, an average of 8.4% of the dose was absorbed (58). Because of its lipophilic nature, DEET was rapidly absorbed
within 2 hours after application; was eliminated from the plasma within 4
hours after being rinsed off the skin; and was primarily excreted in the
urine, mostly within 12 hours. Tape stripping revealed that the chemical
does not accumulate in the stratum corneum.
Bioavailability experiments conducted with Minnetonka Brands' 10% DEET
liposphere formulation showed that percutaneous absorption was one third
of that of a 10% alcohol-based DEET solution (52). In contrast,
U.S. Army studies that used an in vitro pigskin model did not show any
reduced percutaneous absorption (expressed as a percentage of the applied
dose) of the 3M polymer formulation compared with 75% DEET in alcohol (62).
Toxicity
Used by millions of people worldwide for 40 years, DEET has a
remarkable safety profile. As part of the 1980 EPA Reregistration Standard
for DEET, more than 30 studies were conducted to assess acute, chronic,
and subchronic toxicity; mutagenicity; oncogenicity; and developmental,
reproductive, and neurologic toxicity (Table 3) (42, 63,
64). The results of these studies did not require any change to the
product to comply with EPA safety standards, nor did they indicate any new
toxicities with normal use. Studies of high doses of DEET orally
administered to mice and rats did not reveal any potential in humans for
teratogenicity or oncogenicity.
Case reports of potential DEET toxicity exist in the medical literature
and are summarized in Table 4. The reports of greatest concern
involve 14 cases of encephalopathy, 13 of which were in children younger
than 8 years of age (63, 66-71, 75). Three of these children died, 1 of
whom had an ornithine carbamoyl transferase deficiency (67) that
might have predisposed her to DEET-induced toxicity (66). The other
children recovered without sequelae. Many of these persons had a history
of long-term, excessive, or inappropriate use of DEET repellents, and the
details of exposure are frequently poorly documented. Animal studies in
rats and mice have shown that DEET is not a selective neurotoxin (42,
61, 63).
Toxicology studies in rats and dogs in which sublethal intraperitoneal
injections were used revealed that DEET could induce dose-dependent
hypotension and bradycardia; however, these conditions occurred at dosages
that would be almost impossible to attain with cutaneous applications of
DEET (78). Only one case of bradycardia and hypotension has been
documented in the medical literature (79).
Initial repeat-insult patch tests of 100% technical-grade DEET or 50%
DEET in ethanol conducted over 21 consecutive days showed no sign of skin
irritation (42). Subsequently, 14 cases of contact urticaria and
irritant contact dermatitis (mostly in soldiers) have been reported (81-85). The antecubital fossa seems to be particularly sensitive
to developing bullous irritant contact dermatitis if DEET products are
allowed to remain on this area overnight (86).
A 1994 study reviewed 9086 cases of DEET exposure reported to 71 poison
control centers from 1985 to 1989 (76). More than half (54%) of the
persons involved had no symptoms at the time of the call to the poison
control center. The most commonly reported symptoms were related to
spraying repellent in the eyes (DEET is a known eye irritant [42]) or
inhaling it. Symptoms were least likely to occur after accidental
ingestion of small amounts of the repellent. Although most exposures were
in children, there was no evidence that children younger than 6 years of
age were more likely than older children or adults to develop adverse
effects after use of a DEET repellent. No correlation was found between
the severity of symptoms and age, sex, or concentration of applied DEET.
Eighty-eight percent of exposed persons did not require treatment at a
health care facility. Of the patients who were seen, 81% were sent home,
and only 5% required hospitalization. Of the patients in whom follow-up
was available, 99% had no long-term sequelae.
In summary, DEET has had a remarkable safety profile during more than
40 years of use by millions of people worldwide. Careful product choice
and application of the repellent according to EPA guidelines will greatly
reduce the possibility of toxicity. Conservative use of low-concentration
DEET products is most appropriate for children.
Questions about the safety of DEET may be addressed to the
EPA-sponsored National Pesticide Telecommunications Network, available by
telephone every day from 6:30 a.m. to 4:30 p.m. Pacific Standard Time at
800-858-7378 or on the World Wide Web at http://www.ace.orst.edu/info/nptn/.
Skin-So-Soft
Avon (New York, New York) Skin-So-Soft bath oil received considerable
media attention several years ago when some consumers reported it to be
effective as a mosquito repellent. When tested under laboratory conditions
against Aedes aegypti mosquitoes, this product's effective
half-life was 30 minutes. Against Aedes albopictus, Skin-So-Soft
oil provided 40 minutes of protection from bites, a duration 10 times less
than that of 12.5% DEET (46). It has been proposed that the limited
mosquito repellent effect of Skin-So-Soft oil could be caused by its
fragrance or the presence of diisopropyl adipate and benzophenone in the
formulation, both of which have some repellent activity (40). Avon
now markets products under the Skin-So-Soft label that contain an
EPA-recognized repellent (Table 5).
Plant-Derived Repellents
Thousands of plants have been tested as potential sources of insect
repellents (39, 40, 87). None of the plant-derived chemicals tested
to date demonstrate the broad effectiveness and duration of DEET, but a
few show repellent activity. Plants whose essential oils have been
reported to have repellent activity include citronella, cedar, verbena,
pennyroyal, geranium, lavender, pine, cajeput, cinnamon, rosemary, basil,
thyme, allspice, garlic, and peppermint (40, 88-91). Unlike
synthetic insect repellents, plant-derived repellents have been relatively
poorly studied. When tested, most of these essential oils tended to give
short-lasting protection, usually less than 2 hours. Readily available
plant-derived insect repellents are listed in Table 5.
Citronella
Citronella is the active ingredient most commonly found in "natural" or
"herbal" insect repellents marketed in the United States. It is registered
with the EPA as an insect repellent. Citronella oil has a lemony scent and
was originally extracted from the grass plant Cymbopogon nardus.
Limited data are available from studies that directly compared the
efficacy of citronella-based products with that of DEET-based products. In
one study, 0.01 µmol of DEET per L of air was sufficient to prevent 90% of
mosquitoes from landing on their targets; a 1000-fold higher concentration
of citronellol (one of the active chemicals in citronella oil) was
required to achieve a similar effect (31).
Studies show that citronella can be an effective repellent, but it
provides shorter complete protection time than most DEET-based products.
Frequent reapplication of the repellent can partially compensate for this.
The manufacturer of Natrapel (Tender Corp., Littleton, New Hampshire) has
laboratory data showing that their 10% lotion reduced mosquito bites by
84% during a 4-minute test period. In contrast, 14% DEET reduced biting by
96% in the same test period. Buzz Away (Quantum, Inc., Eugene, Oregon)
with 5% citronella oil provided an average protection time of 1.9 hours
against Aedes aegypti (92). In field testing, Buzz Away Oil
provided an average of 88% repellency during a 2-hour exposure. In
general, the repellency of Buzz Away was greatest within the first 40
minutes after application and decreased over the remainder of the test
period (93).
Citronella candles have been promoted as an effective way to repel
mosquitoes in the backyard. One study compared the ability of commercially
available 3% citronella candles, 5% citronella incense, and plain candles
to prevent bites by Aedes mosquitoes under field conditions (94). Persons near the citronella candles had 42% fewer bites than
controls, who had no protection (a statistically significant difference).
However, burning ordinary candles reduced the number of bites by 23%. The
efficacy of citronella incense and plain candles did not differ. The
ability of plain candles to decrease biting may result from their action
as a decoy source of warmth, moisture, and carbon dioxide.
The citrosa plant (Pelargonium citrosum 'van Leenii') has been
marketed as being able to repel mosquitoes through the continuous release
of citronella oils. Unfortunately, when tested, these plants offer no
protection against bites (95, 96).
Bite Blocker
Bite Blocker (Consep, Inc., Bend, Oregon) is a plant-based repellent
that was released in the United States in 1997. Bite Blocker combines
soybean oil, geranium oil, and coconut oil in a formulation that has been
available in Europe for several years (97). Studies conducted at
the University of Guelph, Ontario, Canada, showed that this product gave
more than 97% protection against Aedes mosquitoes under field
conditions, even 3.5 hours after application. During the same period, a
6.65% DEET-based spray afforded 86% protection, and Avon Skin-So-Soft
citronella-based repellent gave only 40% protection (98). A second
study showed that Bite Blocker provided a mean ± SD of 200 ± 30 minutes of
complete protection from mosquito bites (99).
Permethrin
Pyrethrum is a powerful, rapidly acting insecticide, originally derived
from the crushed and dried flowers of the daisy Chrysanthemum
cinerariifolium (100). Permethrin is a human-made synthetic
pyrethroid. It does not repel insects but works as a contact insecticide,
causing nervous system toxicity that leads to the death or "knockdown"
(out of the air) of the insect. The chemical is effective against
mosquitoes, flies, ticks, and chiggers. Permethrin has low toxicity in
mammals, is poorly absorbed by the skin, and is rapidly inactivated by
ester hydrolysis (101).
Permethrin should be applied directly to clothing or other fabrics
(such as tent walls [102] or mosquito nets [103]), not to skin. The spray
form is nonstaining, nearly odorless, and resistant to degradation by heat
or sun and maintains its potency for at least 2 weeks, even through
several launderings (104, 105). The combination of
permethrin-treated clothing and skin application of a DEET-based repellent
creates a formidable barrier against mosquito bites (19, 106, 107).
In a field trial conducted in Alaska, persons wearing permethrin-treated
uniforms and a polymer-based 35% DEET product had more than 99.9%
protection (1 bite/h) over 8 hours, even under conditions of intense
biting pressures; unprotected persons received an average of 1188 bites/h (108).
Permethrin-based insecticide sprays available in the United States are
listed in Table 5. To apply to clothing, spray each side of the
fabric (outdoors) for 30 to 45 seconds, just enough to moisten it. Allow
the garment to dry for 2 to 4 hours before wearing it.
Reducing Local Mosquito Populations
Consumers may still find advertisements for small ultrasonic electronic
devices that are meant to be carried on the body and purportedly emit
sounds that repel mosquitoes. Many studies conducted in the field and
laboratory show that these devices do not work against mosquitoes (109-111). Encouraging natural predation of insects by setting up
bird or bat houses in the backyard has also been unsuccessful in reducing
local mosquito populations (112). Likewise, backyard bug "zappers,"
which lure and electrocute insects, are ineffective (113).
Mosquitoes continue to be more attracted to humans than to the devices.
One study conducted in homeowners' backyards showed that of the insects
killed by these devices, only 0.13% were female mosquitoes (114).
An estimated 71 billion to 350 billion beneficial insects may be killed
annually in the United States by these electrocuting devices (114).
The most effective way to reduce a local population of mosquitoes is to
eliminate sources of standing water, such as old discarded tires, clogged
gutters, planters, bird baths, or tree stump holes.
Relief from Mosquito Bites
Cutaneous responses to mosquito bites range from common localized
wheal-and-flare reactions to delayed bite papules, rare systemic
Arthus-type reactions, and anaphylaxis (115-117). Bite reactions
are the result of sensitization to mosquito salivary antigens, which lead
to the formation of specific IgE and IgG antibodies (118-121).
Immediate-type reactions are mediated by IgE and histamine, whereas
cell-mediated immunity is responsible for the delayed reactions.
Several strategies exist for relieving the itch of mosquito bites.
Topical corticosteroids can reduce the erythema, itching, and induration.
Topical diphenhydramine and caine-containing derivatives should be avoided
because of concerns about inducing allergic contact sensitivity. Oral
antihistamines can be effective in reducing the symptoms of mosquito
bites. Cetirizine was given prophylactically in a double-blind,
placebo-controlled, 2-week, crossover trial to 18 persons who had
previously had dramatic cutaneous reactions to mosquito bites (122). Persons who received the active drug had a statistically
significant 40% decrease in the size of the wheal response at 15 minutes
and the size of the bite papule at 24 hours. The mean pruritus score,
measured 0.25, 1, 12, and 24 hours after the mosquito had bitten, was 67%
less than that of the untreated controls. These studies have not been done
with astemizole, terfenadine, loratadine, or fexofenadine. In highly
sensitized persons, prophylactic treatment with nonsedating antihistamines
may safely reduce the cutaneous reactions to mosquito bites.
Acknowledgments: The author thanks Donald Baumgartner (U.S.
Environmental Protection Agency); Donald Barnard, PhD (U.S. Department of
Agriculture); Nigel Hill (London School of Hygiene and Tropical Medicine);
and Robbin Lindsay, PhD (Department of Environmental Biology, University
of Guelph) for providing data that were not readily available in the
medical literature. The author has received no monetary support from any
of the manufacturers whose products are mentioned in this paper.
Requests for Reprints: Mark S. Fradin, MD, Chapel Hill
Dermatology, 891 Willow Drive, Suite 2, Chapel Hill, NC 27514.
References
1. Taubes G. A mosquito bites
back. The New York Times Magazine. 1977;24 Aug:40-6.
2. Shell ER. Resurgence of a deadly disease. The
Atlantic Monthly. 1997;Aug:45-60.
3. Clements
AN. The Physiology of Mosquitoes. Oxford: Pergamon Pr; 1963.
4. Miike L. Do insects transmit AIDS? Washington,
DC: Office of Technology Assessment Health Program, U.S. Congress; 1987.
5. McHugh CP. Arthropods: vectors of disease
agents. Laboratory Medicine. 1994;25:429-37.
6.
Maibach HI, Skinner WA, Strauss WG, Khan AA. Factors that attract and
repel mosquitoes in human skin. JAMA. 1966;196:263-6.
7. Curtis CF. Fact and fiction in mosquito
attraction and repulsion. Parasitology Today. 1986;2:316-8.
8. Keystone JS. Of bites and body odour. Lancet.
1996;347:1423.
9. Bock GR, Cardew G, eds.
Olfaction in Mosquito-Host Interactions. New York: J Wiley; 1996.
10. Bowen MF. The sensory physiology of
host-seeking behavior in mosquitoes. Annu Rev Entomol. 1991;36:139-58.
11. Davis EE, Bowen MF. Sensory
physiological basis for attraction in mosquitoes. J Am Mosq Control Assoc.
1994;10(2 Pt 2):316-25.
12. Gjullin CM.
Effect of clothing color on the rate of attack of Aedes mosquitoes.
J Econ Entomol. 1947;40:326-7.
13. Gillies
MT. The role of carbon dioxide in host-finding by mosquitoes (Diptera:
Culicidae): a review. Bulletin of Entomological Research. 1980;70:525-32.
14. Gillies MT, Wilkes TJ. The range of
attraction of animal baits and carbon dioxide for mosquitoes. Studies in a
freshwater area of West Africa. Bulletin of Entomological Research.
1972;61:389-404.
15. Snow WF. The effect of
a reduction in expired carbon dioxide on the attractiveness of human
subjects to mosquitoes. Bulletin of Entomological Research. 1970;60:43-8.
16. Davis EE, Sokolove PG. Lactic
acid-sensitive receptors on the antennae of the mosquito, Aedes
aegypti. J Comp Physiol. 1976;105:43-54.
17.
Khan AA. Mosquito attractants and repellents. In: Shorey HH, McKelvey
JJ, eds. Chemical Control of Insect Behavior. New York: J Wiley;
1977:305-25.
18. de Jong R, Knols BG.
Selection of biting sites by mosquitoes. In: Bock GR, Cardew G, eds.
Olfaction in Mosquito-Host Interactions. New York: J Wiley; 1996:89-108.
19. Kline DL, Schreck CE. Personal
protection afforded by controlled-release topical repellents and
permethrin-treated clothing against natural populations of Aedes
taeniorhynchus. J Am Mosq Control Assoc. 1989;5:77-80.
20. Schreck CE, Kline DL, Carlson DA. Mosquito
attraction to substances from the skin of different humans. J Am Mosq
Control Assoc. 1990;6:406-10.
21. Knols BG, de
Jong R, Takken W. Trapping system for testing olfactory responses of
the malarial mosquito Anopheles gambiae in a wind tunnel. Med Vet
Entomol. 1994;8:386-8.
22. Geier M, Sass H, Boeckh J. A search for
components in human body odour that attract females of Aedes
aegypti. In: Bock GR, Cardew G, eds. Olfaction in Mosquito-Host
Interactions. New York: J Wiley; 1996:132-48.
23. Foster WA, Hancock RG. Nectar-related olfactory
and visual attractants for mosquitoes. J Am Mosq Control Assoc. 1994;10 (2
Pt 2):288-96.
24. Curtis CF, Lines JD, Ijumba J,
Callaghan A, Hill N, Karimzad MA. The relative efficacy of repellents
against mosquito vectors of disease. Med Vet Entomol. 1987;1:109-19.
25. Muirhead-Thomson RC. The distribution of
anopheline mosquito bites among different age groups. Br Med J.
1951;1:1114-7.
26. Gilbert IH, Gouck HK, Smith
N. Attractiveness of men and women to Aedes aegypti and
relative protection time obtained with DEET. Florida Entomologist.
1966;49:53-66.
27. Port GR, Boreham PFL. The
relationship of host size to feeding by mosquitoes of the Anopheles
gambiae Giles complex (Diptera: Culicidae). Bulletin of Entomological
Research. 1980;70:133-44.
28. Khan AA, Maibach
HI, Strauss WG, Fenley WR. Vitamin B1 is not a systemic
mosquito repellent in man. Trans St Johns Hosp Dermatol Soc.
1969;55:99-102.
29. Strauss WG, Maibach HI, Khan
AA. Drugs and disease as mosquito repellents in man. Am J Trop Med
Hyg. 1968;17:461-4.
30. Davis EE. Insect
repellents: concepts of their mode of action relative to potential sensory
mechanisms in mosquitoes (Diptera: Culicidae). J Med Entomol.
1985;22:237-43.
31. Wright RH. Why mosquito
repellents repel. Sci Am. 1975;233:104-11.
32.
Rutledge LC, Collister DM, Meixsell VE, Eisenberg GH. Comparative
sensitivity of representative mosquitoes (Diptera: Culicidae) to
repellents. J Med Entomol. 1983;20:506-10.
33.
Schreck CE. Protection from blood-feeding arthropods. In: Auerbach PS,
ed. Wilderness Medicine: Management of Wilderness and Environmental
Emergencies. 3d ed. St. Louis: Mosby; 1995:813-30.
34. Maibach HI, Akers WA, Johnson HL, Khan AA, Skinner
WA. Insects. Topical insect repellents. Clin Pharmacol Ther. 1974;16(5
Part 2):970-3.
35. Maibach HI, Khan AA, Akers
WA. Use of insect repellents for maximum efficacy. Arch Dermatol.
1974;109:32-5.
36. Gabel ML, Spencer TS, Akers
WA. Evaporation rates and protection times of mosquito repellents.
Mosquito News. 1976;36:141-6.
37. Khan AA,
Maibach HI, Skidmore DL. A study of insect repellents: effect of
temperature on protection time. J Econ Entomol. 1972;66:437-8.
38. Quarles W. Lighted and baited mosquito traps.
Common Sense Pest Control. 1996;12:5-11.
39.
Jacobson M, ed. Glossary of plant-derived insect deterrents. Boca
Raton, FL: CRC Pr; 1990.
40. King WV.
Chemicals evaluated as insecticides and repellents at Orlando, Fla. USDA
Agricultural Handbook. 1954;69:1-397.
41.
Materials evaluated as insecticides, repellents, and chemosterilants at
Orlando and Gainesville, Fla., 1952-1964. USDA Agricultural Handbook.
1967;340:1-424.
42. U.S. Environmental
Protection Agency. Office of Pesticides and Toxic Substances. Special
Pesticide Review Division. N,N-diethyl-m-toluamide (DEET) Pesticide
Registration Standard (EPA-540/RS-81-004). Washington, DC: U.S.
Environmental Protection Agency; 1980. (PB81-207722)
43. Rutledge LC, Wirtz RA, Buescher MD, Mehr ZA.
Mathematical models of the effectiveness and persistence of mosquito
repellents. J Am Mosq Control Assoc. 1985;1:56-61.
44. Buescher MD, Rutledge LC, Wirtz RA. Tests of
commercial repellents on human skin against Aedes aegypti. Mosquito
News. 1982;42:428-33.
45. Buescher MD, Rutledge
LC, Wirtz RA, Nelson JH. The dose-persistence relationship of deet
against Aedes aegypti. Mosquito News. 1983;43:364-6.
46. Schreck CE, McGovern TP. Repellents and other
personal protection strategies against Aedes albopictus. J Am Mosq
Control Assoc. 1989;5:247-50.
47. Mehr ZA,
Rutledge LC, Morales EL, Meixsell VE, Korte DW. Laboratory evaluation
of controlled-release insect repellent formulations. J Am Mosq Control
Assoc. 1985;1:143-7.
48. Gupta RK, Rutledge
LC. Laboratory evaluation of controlled-release repellent formulations
on human volunteers under three climatic regimens. J Am Mosq Control
Assoc. 1989;5:52-5.
49. Schreck CE, Kline
DL. Repellency of two controlled-release formulations of deet against Anopheles quadrimaculatus and Aedes taeniorhynchus
mosquitoes. J Am Mosq Control Assoc. 1989;5:91-4.
50. Annis B. Comparison of the effectiveness of two
formulations of deet against Anopheles flavirostris. J Am Mosq
Control Assoc. 1990;6:430-2.
51. Gupta RK,
Rutledge LC. Controlled release repellent formulations on human
volunteers under three climatic regimens. J Am Mosq Control Assoc.
1991;7:490-3.
52. Domb AJ, Marlinsky A, Maniar
M, Teomim L. Insect repellent formulations of N,N-diethyl-m-toluamide
(deet) in a liposphere system: efficacy and skin uptake. J Am Mosq Control
Assoc. 1995;11:29-34.
53. Garrettson LK.
Commentary-DEET: caution for children still needed. J Toxicol Clin
Toxicol. 1997;35:443-5.
54. Shelov SP, ed.
Caring for Your Baby and Young Child: Birth to Age 5. New York: Bantam
Books; 1991:639.
55. U.S. Environmental
Protection Agency, Office of Pesticide Programs. Using Insect Repellents
Safely (EPA-735/F-93-052R). Washington, DC: U.S. Environmental Protection
Agency; 1996.
56. Rutledge LC. Some
corrections to the record on insect repellents and attractants. J Am Mosq
Control Assoc. 1988;4:414-25.
57. Montemarano
AD, Gupta RK, Burge JR, Klein K. Insect repellents and the efficacy of
sunscreens. Lancet. 1997;349:1670-1.
58. Selim
S, Hartnagel RE Jr, Osimitz TG, Gabriel KL, Schoenig GP. Absorption,
metabolism, and excretion of N,N-diethyl-m-toluamide following dermal
application to human volunteers. Fundam Appl Toxicol. 1995;25:95-100.
59. Robbins PJ, Cherniack MG. Review of the
biodistribution and toxicity of the insect repellent
N,N-diethyl-m-toluamide (DEET). J Toxicol Environ Health. 1986;18:503-25.
60. Qiu H, Jun HW, Tao J. Pharmacokinetics
of insect repellent N,N-diethyl-m-toluamide in beagle dogs
following intravenous and topical routes of administration. J Pharm Sci.
1997;86:514-6.
61. Schoenig GP, Hartnagel RE Jr,
Osimitz TG, Llanso S. Absorption, distribution, metabolism, and
excretion of N,N-diethyl-m-toluamide in the rat. Drug Metab
Dispos. 1996;24:156-63.
62. Reifenrath W,
Hawkins G, Kurtz M, Bernardo E, Dahlberg E, Jesse R. Controlled
Release Personal Use Arthropod Repellent Formulation: In Vitro Evaluation
of Evaporation/Penetration Characteristics, Water Wash Resistance, and
Interaction with CW Agent Analogs. San Francisco: Presidio of San
Francisco; Division of Cutaneous Hazards, Letterman Institute of Research;
1986.
63. Osimitz TG, Grothaus RH. The
present safety assessment of DEET. J Am Mosq Control Assoc. 1995;11(2 Pt
2):274-8.
64. Completed Studies for the DEET
Toxicology Data Development Program. Washington, DC: The DEET Joint
Venture Group, Chemical Specialties Manufacturers Association; 1996.
65. Snyder JW, Poe RO, Stubbins JF, Garrettson
LK. Acute manic psychosis following the dermal application of
N,N-diethyl-m-toluamide (DEET) in an adult. Clin Toxicol. 1986;24:429-39.
66. Heick HM, Peterson RG, Dalpe-Scott M,
Qureshi IA. Insect repellent, N,N-diethyl-m-toluamide, effect on
ammonia metabolism. Pediatrics. 1988;82:373-6.
67. Heick HM, Shipman RT, Norman MG, James W.
Reye-like syndrome associated with use of insect repellent in a presumed
heterozygote for ornithine carbamoyl transferase deficiency. J Pediatr.
1980;97:471-3.
68. de Garbino JP, Laborde A.
Toxicity of an insect repellent: N-N-diethyltoluamide. Vet Hum Toxicol.
1983;25:422-3.
69. Zadikoff CM. Toxic
encephalopathy associated with use of insect repellant. J Pediatr.
1979;95:140-2.
70. Osimitz TG, Murphy JV.
Neurological effects associated with use of the insect repellent N,N-diethyl-m-toluamide (DEET). J Toxicol Clin Toxicol.
1997;35:435-41.
71. Lipscomb JW, Kramer JE,
Leikin JB. Seizure following brief exposure to the insect repellent
N,N-diethyl-m-toluamide. Ann Emerg Med. 1992;21:315-7.
72. Gryboski J, Weinstein D, Ordway NK. Toxic
encephalopathy apparently related to the use of an insect repellent. N
Engl J Med. 1961;264:289-91.
73. Roland EH, Jan
JE, Rigg JM. Toxic encephalopathy in a child after brief exposure to
insect repellents. Can Med Assoc J. 1985;132:155-6.
74. Seizures temporally associated with the use of
DEET insect repellent-New York and Connecticut. MMWR Morb Mortal Wkly Rep.
1989;38:678-80.
75. Edwards DL, Johnson CE.
Insect-repellent-induced toxic encephalopathy in a child. Clin Pharm.
1987;6:496-8.
76. Veltri JC, Osimitz TG,
Bradford DC, Page BC. Retrospective analysis of calls to poison
control centers resulting from exposure to the insect repellent
N,N-diethyl-m-toluamide (DEET) from 1985-1989. J Toxicol Clin Toxicol.
1994;32:1-16.
77. Tenenbein M. Severe toxic
reactions and death following the ingestion of diethyltoluamide-containing
insect repellents. JAMA. 1987;258:1509-11.
78.
Leach GJ, Russell RD, Houpt JT. Some cardiovascular effects of the
insect repellent N,N-diethyl-m-toluamide (DEET). J Toxicol Environ Health.
1988;25:217-25.
79. Clem JR, Havemann DF, Raebel
MA. Insect repellent (N,N-diethyl-m-toluamide) cardiovascular toxicity
in an adult. Ann Pharmacother. 1993;27:289-93.
80. Miller JD. Anaphylaxis associated with insect
repellent. N Engl J Med. 1982;307:1341-2.
81.
von Mayenburg J, Rakoski J. Contact urticaria to diethyltoluamide.
Contact Dermatitis. 1994;9:171.
82. Maibach HI,
Johnson HL. Contact urticaria syndrome. Contact urticaria to
diethyltoluamide (immediate-type sensitivity). Arch Dermatol.
1975;111:726-30.
83. Wantke F, Focke M, Hemmer
W, Götz M, Jarisch R. Generalized urticaria induced by a
diethyltoluamide-containing insect repellent in a child. Contact
Dermatitis. 1996;35:186-7.
84. Amichai B,
Lazarov A, Halevy S. Contact dermatitis from diethyltoluamide. Contact
Dermatitis. 1994;30:188.
85. Reuveni H, Yagupsky
P. Diethyltoluamide-containing insect repellent: adverse effects in
worldwide use. Arch Dermatol. 1982;118:582-3.
86. Lamberg SI, Mulrennan JA Jr. Bullous reaction
to diethyl toluamide (DEET). Resembling a blistering insect eruption. Arch
Dermatol. 1969;100:582-6.
87. Sukumar K, Perich
MJ, Boobar LR. Botanical derivatives in mosquito control: a review. J
Am Mosq Control Assoc. 1991;7:210-37.
88.
Quarles W. Botanical mosquito repellents. Common Sense Pest Control.
1996;12:12-9.
89. Grainger J, Moore C.
Natural Insect Repellents for Pets, People and Plants. Austin: The Herb
Bar; 1991.
90. Brown M, Hebert AA. Insect
repellents: an overview. J Am Acad Dermatol. 1997;36(2 Pt 1):243-9.
91. Duke J. USDA Agricultural Research Service
Phytochemical and Ethnobotanical Databases.
(http://www.ars-grin.gov/|mfngrlsb/)
92. Spero
NC. Repellent Testing against Adult Mosquitoes in the Laboratory.
Baltimore: Insect Control and Research; 1993. Sponsored by Quantum, Inc.
93. Surgeoner GA. Efficacy of Buzz Away Oil
against spring Aedes spp. mosquitoes. Guelph, Ontario: Department
of Environmental Biology, University of Guelph; 1995. Sponsored by
Quantum, Inc.
94. Lindsay RL, Surgeoner GA, Heal
JD, Gallivan GJ. Evaluation of the efficacy of 3% citronella candles
and 5% citronella incense for protection against field populations of Aedes mosquitoes. J Am Mosq Control Assoc. 1996;12(2 Pt 1):293-4.
95. Matsuda BM, Surgeoner GA, Heal JD, Tucker
AO, Maciarello MJ. Essential oil analysis and field evaluation of the
citrosa plant "Pelargonium citrosum" as a repellent against
populations of Aedes mosquitoes. J Am Mosq Control Assoc.
1996;12:69-74.
96. Cilek JE, Schreiber ET.
Failure of the "mosquito plant", Pelargonium x citrosum 'van
Leenii', to repel adult Aedes albopictus and Culex
quinquefasciatus in Florida. J Am Mosq Control Assoc. 1994;10:473-6.
97. Finally, a safer insect repellent.
University of California at Berkeley Wellness Letter. 1997;13:2.
98. Lindsay RL, Heal JD, Surgeoner GA. Comparative
evaluation of the efficacy of Bite Blocker, Off! Skintastic, and Avon
Skin-So-Soft to protect against Aedes species mosquitoes in
Ontario. Guelph, Ontario: Department of Environmental Biology, University
of Guelph; 1996. Sponsored by Chemfree Environment, Inc.
99. Lindsay RL, Heal JD, Surgeoner GA. Evaluation
of Bite Blocker as a repellent against spring Aedes spp.
mosquitoes. Guelph, Ontario: Department of Environmental Biology,
University of Guelph; 1996. Sponsored by Chemfree Environment, Inc.
100. Casida JE, Quistad GB. Pyrethrum flowers:
production, chemistry, toxicology and uses. Oxford: Oxford Univ Pr; 1995.
101. Insect repellents. Med Lett Drugs
Ther. 1989;31:45-7.
102. Schreck CE.
Permethrin and dimethyl phthalate as tent fabric treatments against Aedes aegypti. J Am Mosq Control Assoc. 1991;7:533-5.
103. Lines JD, Myamba J, Curtis CF. Experimental
hut trials of permethrin-impregnated mosquito nets and eave curtains
against malaria vectors in Tanzania. Med Vet Entomol. 1987;1:37-51.
104. Schreck CE, Posey K, Smith D. Durability of
permethrin as a potential clothing treatment to protect against
blood-feeding arthropods. J Econ Entomol. 1978;71:397-400.
105. Schreck CE, Carlson DA, Weidhass DE, Posey K,
Smith D. Wear and aging tests with permethrin-treated cotton-polyester
fabric. J Econ Entomol. 1980;73:451-3.
106.
Gupta RK, Sweeney AW, Rutledge LC, Cooper RD, Frances SP, Westrom DR.
Effectiveness of controlled-release personal-use arthropod repellents and
permethrin-impregnated clothing in the field. J Am Mosq Control Assoc.
1987;3:556-60.
107. Sholdt LL, Schreck CE,
Qureshi A, Mammino S, Aziz A, Iqbal M. Field bioassays of
permethrin-treated uniforms and a new extended duration repellent against
mosquitoes in Pakistan. J Am Mosq Control Assoc. 1988;4:233-6.
108. Lillie TH, Schreck CE, Rahe AJ. Effectiveness
of personal protection against mosquitoes in Alaska. J Med Entomol.
1988;25:475-8.
109. Belton P. An acoustic
evaluation of electronic mosquito repellers. Mosquito News. 1981;41:751-5.
110. Lewis DJ, Fairchild WL, Leprince DJ.
Evaluation of an electronic mosquito repeller. Canadian Entomologist.
1982;114:699-702.
111. Foster WA, Lutes KI.
Tests of ultrasonic emissions on mosquito attraction to hosts in a flight
chamber. J Am Mosq Control Assoc. 1985;1:199-202.
112. Mitchell M. Mythical mosquito control. Wing
Beats. 1992;3:18-20.
113. Nasci RS, Harris CW,
Porter CK. Failure of an insect electrocuting device to reduce
mosquito biting. Mosquito News. 1983;43:180-3.
114. Frick TB, Tallamy DW. Density and diversity
of non-target insects killed by suburban electric insect traps.
Entomological News. 1996;2:77-82.
115.
McCormack DR, Salata KF, Hershey JN, Carpenter GB, Engler RJ. Mosquito
bite anaphylaxis: immunotherapy with whole body extracts. Ann Allergy
Asthma Immunol. 1995;74:39-44.
116. Reunala T,
Brummer-Korvenkontio H, Palosuo T. Are we really allergic to mosquito
bites? Ann Med. 1994;26:301-6.
117. Reunala T,
Brummer-Korvenkontio H, Lappalainen P, Rasanen L, Palosuo T.
Immunology and treatment of mosquito bites. Clin Exp Allergy. 1990;20
Suppl 4:19-24.
118. Reunala T, Lappalainen P,
Brummer-Korvenkontio H, Coulie P, Palosuo T. Cutaneous reactivity to
mosquito bites: effect of cetirizine and development of anti-mosquito
antibodies. Clin Exp Allergy. 1991;21:617-22.
119. Brummer-Korvenkontio H, Lappalainen P, Reunala T,
Palosuo T. Immunization of rabbits with mosquito bites: immunoblot
analysis of IgG antimosquito antibodies in rabbit and man. Int Arch
Allergy Appl Immunol. 1990;93:14-8.
120. Peng
Z, Yang M, Simons FE. Immunologic mechanisms in mosquito allergy:
correlation of skin reactions with specific IgE and IgG antibodies and
lymphocyte proliferation response to mosquito antigens. Ann Allergy Asthma
Immunol. 1996;77:238-44.
121.
Brummer-Korvenkontio H, Palosuo T, Francois G, Reunala T.
Characterization of Aedes communis, Aedes aegypti and Anopheles
stephensi mosquito saliva antigens by immunoblotting. Int Arch Allergy
Appl Immunol. 1997;112:169-74.
122. Reunala T,
Brummer-Korvenkontio H, Karppinen A, Coulie P, Palosuo T. Treatment of
mosquito bites with cetirizine. Clin Exp Allergy. 1993;23:72-5.